Collegium Pharmaceutical (COLL) Net Margin (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Net Margin of 7.49% for Q1 2026, up 613.0% year-over-year from 1.05% in Q1 2025, and down 9.28% quarter-over-quarter from 8.26% in Q4 2025.
Collegium Pharmaceutical (COLL) Net Margin (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Net Margin history runs 11 years deep, the most recent figure standing at 7.49% for Q1 2026.
- In Q1 2026, Net Margin rose 613.0% year-over-year to 7.49%; the TTM figure through Mar 2026 stood at 9.41% (up 96.0% YoY), while the FY2025 annual figure was 8.05%, down 290.0% from the prior year.
- Net Margin for Q1 2026 stood at 7.49%, down from 8.26% in the prior quarter.
- The five-year high for Net Margin was 33.66% in Q4 2024, with the low at 15.6% in Q1 2022.
- The 5-year median for Net Margin is 7.49% (2026), against an average of 7.06%.
- Peak annual rise in Net Margin reached 6020 bps in 2022, while the deepest fall reached 9343 bps in 2022.
- Collegium Pharmaceutical's Net Margin stood at 5.12% in 2022, then surged by 517 bps to 21.33% in 2023, then soared by 58 bps to 33.66% in 2024, then tumbled by 75 bps to 8.26% in 2025, then decreased by 9 bps to 7.49% in 2026.
- Business Quant data shows COLL's Net Margin at 7.49% in Q1 2026, 8.26% in Q4 2025, and 15.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | -7.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -116.58% |
| Mar 31, 2026 | 7.49% |
| Dec 31, 2025 | 8.26% |
| Sep 30, 2025 | 15.05% |
| Jun 30, 2025 | 6.37% |
| Mar 31, 2025 | 1.36% |
| Dec 31, 2024 | 33.66% |
| Sep 30, 2024 | 5.86% |
| Jun 30, 2024 | 13.50% |
| Mar 31, 2024 | 19.12% |
| Dec 31, 2023 | 21.33% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 9.60% |
| Mar 31, 2023 | -12.04% |
| Dec 31, 2022 | -5.12% |
| Sep 30, 2022 | 0.36% |
| Jun 30, 2022 | -4.20% |
| Mar 31, 2022 | -15.60% |
| Dec 31, 2021 | -65.31% |
| Sep 30, 2021 | 10.21% |